Use and outcomes of wearable cardioverter-defibrillators in a large integrated academic health system - 16/08/20
Doi : 10.1016/j.ahj.2020.04.007
Peter A. Kahn, MD MPH ThM, Jadry Gruen, MD, Alex Thomas, MD
Yale School of Medicine, Department of Internal Medicine, New Haven, CT
Tariq Ahmad, MD MPH, Nihar R. Desai, MD MPH ⁎ 
Yale School of Medicine, Section of Cardiovascular Medicine, New Haven, CT
⁎Reprint requests: Nihar R. Desai, MD MPH, Yale School of Medicine, Section of Cardiovascular Medicine, 333 Cedar Street, PO Box 20817, New Haven, CT 06520.Yale School of Medicine, Section of Cardiovascular Medicine333 Cedar StreetPO Box 20817New HavenCT06520
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| Article Type: Research Letter |
© 2020
Elsevier Inc. Tutti i diritti riservati.
Vol 226
P. 232-234 - Agosto 2020 Ritorno al numero
Articolo precedente
- Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York
- Nabil Braiteh, Wajeeh ur Rehman, Md Alom, Vincent Skovira, Nour Breiteh, Ibraheem Rehman, Alon Yarkoni, Hisham Kahsou, Afzal Rehman
- Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation – Data from RACE 3
- Bao-Oanh Nguyen, Michiel Rienstra, Anne H. Hobbelt, Jan G.P. Tijssen, Marcelle D. Smit, Robert G. Tieleman, Bastiaan Geelhoed, Dirk J. Van Veldhuisen, Harry J.G.M. Crijns, Isabelle C. Van Gelder, RACE 3 Investigators
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?